Ajinomoto Co., Inc. (TYO:2802)
Japan
· Delayed Price · Currency is JPY | Market Cap | 4.74T |
| Revenue (ttm) | 1.54T |
| Net Income (ttm) | 77.58B |
| Shares Out | 961.06M |
| EPS (ttm) | 79.00 |
| PE Ratio | 62.47 |
| Forward PE | 31.02 |
| Dividend | 48.00 (0.97%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 3,607,300 |
| Average Volume | 5,289,165 |
| Open | 4,826.00 |
| Previous Close | 4,968.00 |
| Day's Range | 4,821.00 - 4,984.00 |
| 52-Week Range | 2,636.50 - 5,025.00 |
| Beta | 0.09 |
| RSI | 79.03 |
| Earnings Date | Feb 5, 2026 |
About Ajinomoto Co.
Ajinomoto Co., Inc. engages in the seasonings and foods, frozen foods, and healthcare and other businesses in Japan and internationally. The Seasonings and Foods segment offers sauces and seasoning products under the AJI-NO-MOTO, HON-DASHI, Cook Do, Ajinomoto KK Consommé, Pure Select Mayonnaise, Ros Dee, Masako, Aji-ngon, Sazón, Sajiku, and CRISPY FRY names. This segment also provides instant noodles under the Knorr Cup Soup and YumYum names; coffee beverages under the Birdy and Blendy brands; powdered drink under the Birdy 3in1 name; MAXIM bra... [Read more]
Financial Performance
In fiscal year 2025, Ajinomoto Co.'s revenue was 1.53 trillion, an increase of 6.35% compared to the previous year's 1.44 trillion. Earnings were 70.27 billion, a decrease of -19.34%.
Financial StatementsNews
Q3 2026 Ajinomoto Co Inc Earnings Presentation Transcript
Q3 2026 Ajinomoto Co Inc Earnings Presentation Transcript
Ajinomoto Co GAAP EPS of ¥91.82, revenue of ¥1.16B
Ajinomoto Co press release (AJINY): 9M GAAP EPS of ¥91.82. Revenue of ¥1.16B.
Ajinomoto Co., Inc. (AJINY) Q3 2026 Earnings Call Transcript
Ajinomoto Co., Inc. (AJINY) Q3 2026 Earnings Call Transcript
Ajinomoto Co., Inc. 2026 Q3 - Results - Earnings Call Presentation
Ajinomoto Co., Inc. (AJINY) Q2 2026 Earnings Call Transcript
Ajinomoto Co., Inc. (OTCPK:AJINY) Q2 2026 Earnings Call November 6, 2025 4:00 AM EST Company Participants Masataka Kaji - General Manager of IR Group - Global Finance Department Shigeo Nakamura - Pres...
Ajinomoto Co., Inc. - Special Call
Ajinomoto Co., Inc. - Special Call Company Participants Masataka Kaji Shigeo Nakamura - President, CEO, Representative Executive Officer & Director Naoko Yamamoto - Executive Officer Normando Filho Na...
Ajinomoto Co., Inc. (AJINY) Q1 2026 Earnings Call Transcript
Ajinomoto Co., Inc. (OTCPK:AJINY) Q1 2026 Earnings Conference Call August 4, 2025 4:00 AM ET Company Participants Masataka Kaji - Former General Manager of IR Group, Global Finance Department Conferen...
Ajinomoto Co., Inc. (AJINY) Q4 2025 Earnings Call Transcript
Ajinomoto Co., Inc. (OTCPK:AJINY) Q4 2025 Results Conference Call May 8, 2025 5:00 AM ET Company Participants Masataka Kaji - Investor Relations Department Shigeo Nakamura - President, CEO & Represent...
Part of $1 Billion Investment Strategy, PCI Pharma Services Completes Acquisition of Ajinomoto Althea, Enhancing US Drug Product Manufacturing for Aseptic Filling of Prefilled Syringes & Cartridges
PHILADELPHIA--(BUSINESS WIRE)--PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – has completed its a...
L-Phenylalanine Market Insights and Forecast to 2030 Featuring Profiles (SWOT, Sales, Prices) of Key Players - Evonik, Ajinomoto, Daesang, and Wuxi Jinghai Amino Acid Co.
Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "L-Phenylalanine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application" report has been added to...
L-Alanyl-L-Glutamine Market Report 2025: Includes Insights Into the Sales, Revenue, Price, Gross Margin & SWOT of Kyowa Hakko, Ajinomoto, and Evonik
Dublin, April 25, 2025 (GLOBE NEWSWIRE) -- The "L-Alanyl-L-Glutamine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application" report has been add...
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
PHILADELPHIA--(BUSINESS WIRE)--PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is acquiring an ent...
Ajinomoto Co., Inc. (AJINY) Q2 2024 Earnings Call Transcript
Ajinomoto Co., Inc. (OTCPK:AJINY) Q2 2024 Earnings Conference Call November 7, 2024 4:00 AM ET Company Participants Masataka Kaji - Investor Relations Department Taro Fujie - Representative Executive ...
Ajinomoto Co., Inc. (AJINY) Q1 2024 Earnings Call Transcript
Ajinomoto Co., Inc. (OTCPK:AJINY) Q1 2024 Earnings Conference Call August 5, 2024 4:00 AM ET Company Participants Masataka Kaji - GM Taro Fujie - Director, Representative Executive Officer, President ...
Ingredients Pioneer Ajinomoto Health & Nutrition Partners with Shiru, Leveraging AI to Discover and Develop Sweet Proteins for Use in Beverages and Specialty Products
BERKELEY, Calif.--(BUSINESS WIRE)--Ajinomoto Health & Nutrition Partners with Shiru, Leveraging AI to Discover and Develop Sweet Proteins for Use in Beverages and Specialty Products.
Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium
Leveraging Advanced Manufacturing and Strict Quality Control for Superior Performance in Cellular Medicine TOKYO , March 26, 2024 /PRNewswire/ -- Today, Ajinomoto Co., Inc. ("Ajinomoto Co.") (TSE: 28...
Essential Japanese Semi Companies For The Reshoring Age
The global COVID-19 pandemic has led to a shift towards reshoring in the semiconductor industry as supply chains are disrupted and geopolitical tensions rise. Reshoring efforts are leading to increase...
Seviroli Foods Acquires a Portfolio of Italian Food Products from Ajinomoto Foods North America
GARDEN CITY, N.Y.--(BUSINESS WIRE)--Seviroli Foods LLC (“Seviroli”), a portfolio company of Mill Point Capital LLC (“Mill Point”) and a leading manufacturer of frozen pasta and other food products and...
Ajinomoto: Food, Biotech, And Semis All-In-One
Ajinomoto is diversifying its revenue segments, particularly in the biopharma and semiconductor industries, for organic growth opportunities. The company has a leading market position, high R&D invest...
Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1
COLUMBUS, Ohio--(BUSINESS WIRE)--Ajinomoto Co., Inc. ("Ajinomoto Co."; TYO: 2802) and Forge Biologics (Forge), announced today that they have entered into a definitive agreement by which Ajinomoto Co....
Ajinomoto May Build New Factory for Chip Film
Ajinomoto says it may build an additional manufacturing base to produce more of its signature chipmaking film. Aside from its seasonings and food products, the Japanese firm also makes the Ajinomoto B...
Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase
TOKYO , Feb. 22, 2023 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce ...
Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
TOKYO , Jan. 10, 2023 /PRNewswire/ -- Ajinomoto Co., Inc. ("Ajinomoto Co.") today announced a license agreement with Exelixis, Inc. ("Exelixis") to incorporate AJICAP®, Ajinomoto Co.'s proprietary sit...